Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels.
Martínez-González J, Alfón J, Berrozpe M, Badimon L. Martínez-González J, et al. Among authors: berrozpe m. Atherosclerosis. 2001 Nov;159(1):27-33. doi: 10.1016/s0021-9150(01)00469-5. Atherosclerosis. 2001. PMID: 11689203
[Neovascularization in human coronary arteries with lesions of different severity].
Juan-Babot JO, Martínez-González J, Berrozpe M, Badimon L. Juan-Babot JO, et al. Among authors: berrozpe m. Rev Esp Cardiol. 2003 Oct;56(10):978-86. doi: 10.1016/s0300-8932(03)76995-4. Rev Esp Cardiol. 2003. PMID: 14563292 Free article. Spanish.
Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages.
Llorente-Cortés V, Royo T, Otero-Viñas M, Berrozpe M, Badimon L. Llorente-Cortés V, et al. Among authors: berrozpe m. Cardiovasc Res. 2007 Jun 1;74(3):526-36. doi: 10.1016/j.cardiores.2007.02.020. Epub 2007 Feb 21. Cardiovasc Res. 2007. PMID: 17376415
Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery.
Tanner FC, van der Loo B, Shaw S, Greutert H, Bachschmid MM, Berrozpe M, Rozenberg I, Blau N, Siebenmann R, Schmidli J, Meyer P, Lüscher TF. Tanner FC, et al. Among authors: berrozpe m. Basic Res Cardiol. 2007 Jul;102(4):308-17. doi: 10.1007/s00395-007-0650-7. Epub 2007 Mar 15. Basic Res Cardiol. 2007. PMID: 17356797 Free article.
Intracellular lipid accumulation, low-density lipoprotein receptor-related protein expression, and cell survival in vascular smooth muscle cells derived from normal and atherosclerotic human coronaries.
Llorente-Cortés V, Otero-Viñas M, Berrozpe M, Badimon L. Llorente-Cortés V, et al. Among authors: berrozpe m. Eur J Clin Invest. 2004 Mar;34(3):182-90. doi: 10.1111/j.1365-2362.2004.01316.x. Eur J Clin Invest. 2004. PMID: 15025676
Heterogeneity of smooth muscle cells in advanced human atherosclerotic plaques: intimal smooth muscle cells expressing a fibroblast surface protein are highly activated by platelet-released products.
Martínez-González J, Berrozpe M, Varela O, Badimon L. Martínez-González J, et al. Among authors: berrozpe m. Eur J Clin Invest. 2001 Nov;31(11):939-49. doi: 10.1046/j.1365-2362.2001.00920.x. Eur J Clin Invest. 2001. PMID: 11737236
Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors.
Alfon J, Guasch JF, Berrozpe M, Badimon L. Alfon J, et al. Among authors: berrozpe m. Atherosclerosis. 1999 Aug;145(2):325-31. doi: 10.1016/s0021-9150(99)00084-2. Atherosclerosis. 1999. PMID: 10488960
Cell biology of restenosis post-angioplasty.
Badimon L, Alfon J, Royo T, Berrozpe M, Martinez-Gonzalez J, Vidal F, Chesebro JH, Fuster V, Badimon JJ. Badimon L, et al. Z Kardiol. 1995;84 Suppl 4:145-9. Z Kardiol. 1995. PMID: 8585267 Review.
Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk.
Palazón CP, Alfón J, Gaffney P, Berrozpe M, Royo T, Badimon L. Palazón CP, et al. Among authors: berrozpe m. Atherosclerosis. 1998 Feb;136(2):333-45. doi: 10.1016/s0021-9150(97)00236-0. Atherosclerosis. 1998. PMID: 9543105
11 results
Jump to page
Feedback